Malignant neoplasm of lung
|
0.010 |
Biomarker
|
disease |
BEFREE |
RNA-binding motif 4 (RBM4) has been reported to play an important role in many human tumors such as lung cancer, breast cancer, ovarian cancer and gastric cancer by regulating alternative splicing and messenger RNA (mRNA) translation.
|
28138257 |
2017 |
Malignant neoplasm of esophagus
|
0.010 |
Biomarker
|
disease |
BEFREE |
In situ hybridization and RNA immunoprecipitation assays demonstrated that TPM1-AS was located in the nucleus and interacted with RNA-binding motif protein 4 (RBM4) in human esophageal cancer cells.
|
28754317 |
2017 |
Carcinoma of lung
|
0.010 |
Biomarker
|
disease |
BEFREE |
RNA-binding motif 4 (RBM4) has been reported to play an important role in many human tumors such as lung cancer, breast cancer, ovarian cancer and gastric cancer by regulating alternative splicing and messenger RNA (mRNA) translation.
|
28138257 |
2017 |
Primary malignant neoplasm of lung
|
0.010 |
Biomarker
|
disease |
BEFREE |
RNA-binding motif 4 (RBM4) has been reported to play an important role in many human tumors such as lung cancer, breast cancer, ovarian cancer and gastric cancer by regulating alternative splicing and messenger RNA (mRNA) translation.
|
28138257 |
2017 |
Malformations of Cortical Development, Group II
|
0.010 |
Biomarker
|
disease |
BEFREE |
Finally, we showed that the full-length Dab1, but not exon 7/8-truncated Dab1, rescued neuronal migration defects in RBM4-depleted neurons, indicating that RBM4 plays a role in neuronal migration via modulating the expression of Dab1 splice isoforms.
|
29581187 |
2018 |
Liver carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Our data implicate RBM4 as a novel prognostic marker and a potential therapeutic target for HCC.
|
28138257 |
2017 |
Neoplasms
|
0.050 |
AlteredExpression
|
group |
BEFREE |
RBM4 expression, together with tumor numbers, capsular formation, vascular invasion and Barcelona clinic liver cancer (BCLC) stage, was an independent prognostic factor for overall survival rate and disease-free survival rate of HCC.
|
28138257 |
2017 |
Neoplasms
|
0.050 |
AlteredExpression
|
group |
BEFREE |
RBM4 cDNA probing of a cancer cDNA array involving 18 different tumor types from 13 different tissues and matching normal tissue found overexpression of RBM4 mRNA (p<0.01) in cervical, breast, lung, colon, ovarian and rectal cancers.
|
26898347 |
2016 |
Malignant Neoplasms
|
0.040 |
AlteredExpression
|
group |
BEFREE |
Strikingly, RBM4 expression is decreased dramatically in cancer patients, and the RBM4 level correlates positively with improved survival.
|
25203323 |
2014 |
Primary malignant neoplasm
|
0.040 |
AlteredExpression
|
group |
BEFREE |
Strikingly, RBM4 expression is decreased dramatically in cancer patients, and the RBM4 level correlates positively with improved survival.
|
25203323 |
2014 |
Malignant neoplasm of stomach
|
0.030 |
AlteredExpression
|
disease |
BEFREE |
Further, lower RBM4 expression is an independent prognostic marker for gastric cancer.
|
27324405 |
2016 |
Stomach Carcinoma
|
0.030 |
AlteredExpression
|
disease |
BEFREE |
Further, lower RBM4 expression is an independent prognostic marker for gastric cancer.
|
27324405 |
2016 |
Rectal Carcinoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
RBM4 cDNA probing of a cancer cDNA array involving 18 different tumor types from 13 different tissues and matching normal tissue found overexpression of RBM4 mRNA (p<0.01) in cervical, breast, lung, colon, ovarian and rectal cancers.
|
26898347 |
2016 |
Secondary malignant neoplasm of lymph node
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
There was a significant association between reduced RBM4 protein expression and differentiation (P < 0.001), lymph node metastasis (P = 0.026), TNM state (P = 0.014) and distant metastasis (P = 0.036).
|
27324405 |
2016 |
Tauopathies
|
0.010 |
AlteredExpression
|
group |
LHGDN |
Our work also suggests that down-regulating tau exon 10 splicing activators, such as RBM4, may be of therapeutic potential in tauopathies involving excessive tau exon 10 inclusion.
|
16777844 |
2006 |
Tumor Cell Invasion
|
0.010 |
AlteredExpression
|
phenotype |
BEFREE |
Re-expression of RBM4 inhibited the proliferation, migration, and invasion of GC cells, while promoting apoptosis.
|
31145716 |
2019 |